Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 4 Issue: 8, December

Mammalian Target of Rapamycin (mTOR) Inhibitors as Anti-Cancer Agents

Volume:4   Issue: 8
Pp: 621-635
Ravi D. Rao, Jan C. Buckner and Jann N. Sarkaria
DOI: 10.2174/1568009043332718
Published on: 01 March, 2012

Targeting the STAT Pathway in Head and Neck Cancer: Recent Advances and Future Prospects

Volume:4   Issue: 8
Pp: 637-651
N. G. Nikitakis, H. Siavash and J. J. Sauk
DOI: 10.2174/1568009043332736
Published on: 01 March, 2012

Wnt / β-Catenin Signaling Pathway as Novel Cancer Drug Targets

Volume:4   Issue: 8
Pp: 653-671
Hue H. Luu, Ruiwen Zhang, Rex C. Haydon, Elizabeth Rayburn, Quan Kang, Weike Si, Jong Kyung Park, Hui Wang, Ying Peng, Wei Jiang and Tong- Chuan He
DOI: 10.2174/1568009043332709
Published on: 01 March, 2012

Surface Antigens/Receptors for Targeted Cancer Treatment: The GnRH Receptor / Binding Site for Targeted Adenocarcinoma Therapy

Volume:4   Issue: 8
Pp: 673-687
R. Eaveri, A. Ben-Yehudah and H. Lorberboum-Galski
DOI: 10.2174/1568009043332745
Published on: 01 March, 2012

Bacteria and Bacterial Toxins as Therapeutic Agents for Solid Tumors

Volume:4   Issue: 8
Pp: 689-702
P. Michl and T. M. Gress
DOI: 10.2174/1568009043332727
Published on: 01 March, 2012